GlassScriptPhysician profile
Grace Aina Jarrett
NPI 1679216329
$41,991.14
in general payments reported to CMS, 2019-2025
22 companies · $35K in 2025
The $35K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,120 · 2023: $2,061 · 2024: $3,370 · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $28K · Food and Beverage: $9,432 · Travel and Lodging: $2,879 · Consulting Fee: $600 · Education: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,787.50 |
| Food and Beverage | $9,431.82 |
| Travel and Lodging | $2,879.15 |
| Consulting Fee | $600.00 |
| Education | $172.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $35,553.26 | 2022-2025 | |
| Ucb, INC. | $1,179.96 | 2022-2025 | Bimzelx, Cimzia |
| Regeneron Healthcare Solutions, INC. | $768.33 | 2022-2025 | Dupixent, Libtayo |
| E.R. Squibb & Sons, L.L.C. | $530.27 | 2023-2025 | Sotyktu |
| Janssen Biotech, INC. | $504.22 | 2022-2025 | Tremfya |
| Journey Medical Corporation | $502.30 | 2022-2025 | |
| Pfizer INC. | $433.02 | 2022-2025 | |
| Incyte Corporation | $352.30 | 2022-2025 | Opzelura |
| Genzyme Corporation | $309.59 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $300.86 | 2024-2025 | |
| Leo Pharma INC. | $271.29 | 2023-2025 | Adbry, Anzupgo |
| Lilly USA, LLC | $261.67 | 2022-2025 | Ebglyss, Taltz |
| Sun Pharmaceutical Industries INC. | $257.46 | 2022-2025 | |
| Galderma Laboratories, L.P. | $166.40 | 2023-2025 | Nemluvio |
| Arcutis Biotherapeutics, INC. | $147.03 | 2023-2025 | Zoryve |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $138.50 | 2022-2024 | Vtama |
| Organon LLC | $120.03 | 2025 | Vtama |
| Cipher Pharmaceuticals US LLC | $66.99 | 2025 | Spinosad, Natroba |
| Almirall LLC | $42.00 | 2025 | Seysara |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $37.37 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.71 | 2024 | Spevigo |
| Mayne Pharma Commercial LLC | $21.58 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Jarrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.